Stay updated on Nivolumab Switch for Metastatic Renal Cell Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Switch for Metastatic Renal Cell Carcinoma Clinical Trial page.
Latest updates to the Nivolumab Switch for Metastatic Renal Cell Carcinoma Clinical Trial page
- Check2 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.1%
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.1%
- Check24 days agoChange DetectedThe website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.SummaryDifference0.2%
- Check52 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.1%
- Check60 days agoChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study and includes a reference to the Contacts and Locations section.SummaryDifference2%
- Check74 days agoChange DetectedThe website has added new features, while several detailed options for data download and participant information have been removed.SummaryDifference3%
Stay in the know with updates to Nivolumab Switch for Metastatic Renal Cell Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Switch for Metastatic Renal Cell Carcinoma Clinical Trial page.